Join us for this webinar to gain insight into targeted therapy in lung cancer. Our expert speaker Dr Malinda Itchins will provide an overview of how targeted therapy works, why it differs from other forms of treatment and how can it be used in lung cancer treatment. You will also gain insight into what you may expect and guidance to help you prepare If undergoing targeted therapy.
A question-and-answer session will take place during the webinar so you can gain answers to your questions live.
Speaker: Dr Malinda Itchins
Dr Malinda Itchins, BMedSci, MBBS(Hons1), PhD, FRACP, is a thoracic medical oncologist at Royal North Shore Hospital, Genesis Care, and North Shore Private. In 2020 she graduated from her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically, and via a clinical trial in progress ALKternate. Malinda is the Lung Cancer Chair for the Clinical Oncology of Australia (COSA) Council, and Early Career Representative for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is Primary Investigator on a number of lung cancer clinical trials and her research focus to date has been in patterns of care, the real-world experience and drug resistance in oncogene driven lung cancers. She is passionate about the evolution of precision medicine in lung cancer.